Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: A prospective prognostic indicator

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 12, 2014, Pages 864-872

  Silakit, Runglawan ^a,b   Loilome, Watcharin ^a,b   Yongvanit, Puangrat ^a,b   Chusorn, Porncheera ^a,b   Techasen, Anchalee ^b   Boonmars, Thidarut ^a,b   Khuntikeo, Narong ^a,b   Chamadol, Nittaya ^a,b   Pairojkul, Chawalit ^a,b   Namwat, Nisana ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cholangiocarcinoma; Opisthorchis viverrini; Prognostic indicator; Serum miR 192

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 103; MICRORNA 106B; MICRORNA 122; MICRORNA 124; MICRORNA 125B; MICRORNA 130B; MICRORNA 143; MICRORNA 148; MICRORNA 150; MICRORNA 191; MICRORNA 192; MICRORNA 193A; MICRORNA 200B; MICRORNA 200C; MICRORNA 21; MICRORNA 223; MICRORNA 23A; MICRORNA 25; MICRORNA 26A; MICRORNA 27A; MICRORNA 374A; MICRORNA 375; MICRORNA 376C; MICRORNA 885; MICRORNA 92A; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; GALLBLADDER CANCER; GALLBLADDER METASTASIS; HAMSTER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONHUMAN; OPISTHORCHIS VIVERRINI; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BILE DUCT TUMOR; BLOOD; GENETICS; INTRAHEPATIC BILE DUCT; MESOCRICETUS; MIDDLE AGED; OPISTHORCHIASIS; OPISTHORCHIS; PARASITOLOGY; PROGNOSIS; PROSPECTIVE STUDY; THAILAND;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; MALE; MESOCRICETUS; MICRORNAS; MIDDLE AGED; OPISTHORCHIASIS; OPISTHORCHIS; PROGNOSIS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; THAILAND; TUMOR MARKERS, BIOLOGICAL;

EID: 84912130874     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.145     Document Type: Article

References (38)

1. Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM,. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health. 2004; 9: 588-594.
2. Chamadol N, Pairojkul C, Khuntikeo N, Laopaiboon V, Loilome W, Sithithaworn P, et al. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients. J Hepatobiliary Pancreat Sci. 2014; 21: 316-322.
3. Khan SA, Miras A, Pelling M, Taylor-Robinson SD,. Cholangiocarcinoma and its management. Gut. 2007; 56: 1755-1756.
4. Wongkham S, Silsirivanit A,. State of serum markers for detection of cholangiocarcinoma. Asian Pac J Cancer Prev. 2012; 13 (Suppl): 17-27.
5. Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD,. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci. 2005; 50: 1734-1740.
6. Bamrungphon W, Prempracha N, Bunchu N, Rangdaeng S, Sandhu T, Srisukho S, et al. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Cancer Lett. 2007; 247: 301-308.
7. Silsirivanit A, Araki N, Wongkham C, Pairojkul C, Narimatsu Y, Kuwahara K, et al. A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. Cancer. 2011; 117: 3393-3403.
8. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-297.
9. Lee YS, Dutta A,. MicroRNAs in cancer. Annu Rev Pathol. 2009; 4: 199-227.
10. Garzon R, Calin GA, Croce CM,. MicroRNAs in cancer. Annu Rev Med. 2009; 60: 167-179.
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105: 10513-10518.
12. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008; 18: 997-1006.
13. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol. 2011; 29: 4781-4788.
14. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ,. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol. 2011; 6: 482-488.
15. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009; 58: 1375-1381.
16. Hausler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer. 2010; 103: 693-700.
17. Chen ZH, Zhang GL, Li HR, Luo JD, Li ZX, Chen GM, et al. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Prostate. 2012; 72: 1443-1452.
18. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006; 130: 2113-2129.
19. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, et al. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology. 2009; 49: 1595-1601.
20. Chusorn P, Namwat N, Loilome W, Techasen A, Pairojkul C, Khuntikeo N, et al. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Tumour Biol. 2013; 34: 1579-1588.
21. Chen L, Yan HX, Yang W, Hu L, Yu LX, Liu Q, et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol. 2009; 50: 358-369.
22. Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T,. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene. 2008; 27: 378-386.
23. Braconi C, Huang N, Patel T,. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology. 2010; 51: 881-890.
24. Zhang J, Han C, Wu T,. MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin. Gastroenterology. 2012; 143: 246-256.
25. Dechakhamphu S, Pinlaor S, Sitthithaworn P, Bartsch H, Yongvanit P,. Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters. Mutat Res. 2010; 691: 9-16.
26. Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Sakai H, et al. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann Surg Oncol. 2010; 17: 3120-3128.
27. Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer. 2013; 108: 644-652.
28. Zhao C, Zhang J, Zhang S, Yu D, Chen Y, Liu Q, et al. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Oncol Rep. 2013; 30: 276-284.
29. Matsumoto S, Sakata Y, Suna S, Nakatani D, Usami M, Hara M, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013; 113: 322-326.
30. Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology. 2011; 54: 1767-1776.
31. Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2012; 316: 196-203.
32. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE. 2009; 4: e5532.
33. Yongvanit P, Pinlaor S, Bartsch H,. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Parasitol Int. 2012; 61: 130-135.
34. Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, Mairiang E, et al. The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends Parasitol. 2012; 28: 395-407.
35. Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, Mori Y, et al. MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene. 2011; 30: 1577-1585.
36. Luzna P, Gregar J, Uberall I, Radova L, Prochazka V, Ehrmann J, Jr,. Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol. 2011; 6: 114.
37. Chung AC, Huang XR, Meng X, Lan HY,. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol. 2010; 21: 1317-1325.
38. Hasebe T, Sasaki S, Imoto S, Ochiai A,. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol. 2001; 14: 325-337.